Oscar Health, Inc.
OSCRNYSEFinancials · Hospital & Medical Service Plans · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $28.6M | $20.6M | $21.4M | $64.9M | $5.4M | $0 |
| Operating income | −$396.4M | $57.3M | −$235.6M | −$589.9M | −$544.5M | −$402.3M |
| Net income | −$443.2M | $25.4M | −$270.7M | −$606.3M | −$572.6M | −$406.8M |
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B |
| Equity | $977.6M | $1.01B | $804.0M | $890.4M | $1.39B | −$1.30B |
| EPS (diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 |
| Shares out. | 262.4M | 265.9M | 221.7M | 212.5M | 179.0M | 29.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −1386.2%
- Net margin
- −1549.9%
- Return on equity
- −45.3%
- Return on assets
- −7.0%
- Return on capital (ROCE)
- −27.1%
- Liabilities / assets
- 84.5%
- Debt / equity
- 5.47×
- Book value / share
- $3.73
- Revenue growth (YoY)
- 39.0%
- Net income growth (YoY)
- −1842.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.19distress
- Accruals / assets
- −24.3%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 27, 2026
- Dragoneer Investment Group, LlcPassive (13G)Feb 17, 2026
- T. Rowe Price Investment Management, Inc.Passive (13G)Nov 14, 2025
- Flynn James EPassive (13G)Nov 13, 2025
- Jpmorgan Chase & CoPassive (13G)Jul 31, 2025
- Blackrock, Inc.Passive (13G)Jul 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 18.4M | 1.8 | -24.7% |
| Apr 30, 2026 | 24.4M | 4.5 | -6.7% |
| Apr 15, 2026 | 26.2M | 3.9 | -1.3% |
| Mar 31, 2026 | 26.5M | 4.0 | +0.6% |
| Mar 13, 2026 | 26.3M | 3.8 | +2.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Regulation FD disclosureApr 21, 2026
- Regulation FD disclosureMar 2, 2026
- Entered a material agreement · Results of operations · New financial obligationFeb 10, 2026
- Director / officer changeDec 29, 2025
- Results of operations · Other material eventNov 6, 2025
- Entered a material agreement · New financial obligation · Unregistered equity saleSep 18, 2025
- Terminated a material agreement · Other material eventSep 16, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.